| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -1.4 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -1.1 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.96 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.69 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.63 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.46 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.39 | 0.008 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.6 |